Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination
Issue Cover
Current Issue
Volume 9,
Issue 1,
January 14 2025
View This Issue

Latest Articles

Predicting CAR T-cell toxicity: insurance for CAR crashes
Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy
T-cell immune cluster analysis using CyTOF identifies unique subgroups of patients with acute myeloid leukemia
Deficit accumulation frailty index and treatment tolerability in AML: data from CALGB 11001 and 11002 (Alliance)
Optical genome mapping identified deletions, inversions, and insertions in hemophilia
Cerebral vascular shunting and oxygen metabolism in sickle cell disease
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era
Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response
Amelioration of a von Willebrand disease type 2B phenotype in vivo upon treatment with allele-selective siRNAs
CHIP away at the marrow-clot connection: inflammation, clonal hematopoiesis, and thromboembolic disease

Advertisement intended for health care professionals

Nearly 17,000 citations
earned in 2023

Year in review: Blood Advances' ten most read articles published in 2024
Acknowledgement of Reviewers
ASH Commitment to Diversity, Equity, and Inclusion in Health Care

Featured Content

Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children’s Oncology Group AALL1931 study

Cardiovascular toxicities associated with novel cellular immune therapies

Digital cognitive behavioral therapy vs education for pain in adults with sickle cell disease

Local radiation enhances systemic CAR T-cell efficacy by augmenting antigen crosspresentation and T-cell infiltration

Evolving consolidation patterns and outcomes for a large cohort of patients with primary CNS lymphoma

HIV infection is associated with compromised tumor microenvironment adaptive immune reactivity in Hodgkin Lymphoma

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals